We are live on
!
Find out more
Balyasny Asset Management Portfolio holdings
AUM
$77.1B
1-Year Est. Return
42.89%
This Fund
S&P 500
This Quarter
Est. Return
+6.09%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$22B
AUM Growth
+$103K
(+0%)
Cap. Flow
-$916M
Cap. Flow
% of AUM
-4.16%
Top 10 Holdings %
Top 10 Hldgs %
10.55%
Holding
2,302
New
567
Increased
501
Reduced
537
Closed
688
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$168M |
| 2 |
CenterPoint Energy
CNP
|
+$151M |
| 3 |
Netflix
NFLX
|
+$132M |
| 4 |
Equifax
EFX
|
+$132M |
| 5 |
Sempra
SRE
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$335M |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$166M |
| 3 |
CMA
Comerica
CMA
|
+$164M |
| 4 |
DuPont de Nemours
DD
|
+$144M |
| 5 |
Dollar Tree
DLTR
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.98% |
| 2 | Technology | 10.51% |
| 3 | Consumer Discretionary | 10.34% |
| 4 | Industrials | 8.24% |
| 5 | Healthcare | 7.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Olin
OLN
$2.12B
| $13.3M | 0.06% |
519,514
-484,505
| -48% | -$14.2M |
|
|
ADAP
402
DELISTED
Adaptimmune Therapeutics
ADAP
| $13.3M | 0.06% |
982,000
+165,716
| +20% | +$1.74M |
|
403
Kilroy Realty
KRC
$4.42B
| $13.3M | 0.06% |
184,925
+178,905
| +2,972% | +$13M |
|
404
International Flavors & Fragrances
IFF
$21.9B
| $13.3M | 0.06% |
95,257
+85,230
| +850% | +$11.2M |
|
405
PUT
American Express
AXP
$230B
| $13.2M | 0.06% |
+120,000
| New | +$12.5M |
|
406
PUT
Perrigo
PRGO
$1.78B
| $13.2M | 0.06% |
+180,000
| New | +$13.5M |
|
|
AQUA
407
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $13.1M | 0.06% |
+739,149
| New | +$14.5M |
|
|
FDC
408
DELISTED
First Data Corporation
FDC
| $13.1M | 0.06% |
+534,230
| New | +$12.9M |
|
|
SPLK
409
DELISTED
Splunk Inc
SPLK
| $12.9M | 0.06% |
106,437
-237,035
| -69% | -$26.3M |
|
410
Performance Food Group
PFGC
$18B
| $12.8M | 0.06% |
383,779
+49,916
| +15% | +$1.76M |
|
411
Comcast
CMCSA
$90B
| $12.8M | 0.06% |
360,545
-528,754
| -59% | -$18.7M |
|
|
CLVS
412
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
| $12.7M | 0.06% |
395,000
+237,500
| +151% | +$9.19M |
|
413
Moelis & Co
MC
$4.94B
| $12.7M | 0.06% |
231,385
+221,848
| +2,326% | +$13M |
|
414
Insulet
PODD
$9.79B
| $12.6M | 0.06% |
119,237
-70,499
| -37% | -$6.6M |
|
415
NVIDIA
NVDA
$5.42T
| $12.6M | 0.06% |
1,798,000
+857,920
| +91% | +$5.58M |
|
|
ICPT
416
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $12.5M | 0.06% |
105,000
+62,000
| +144% | +$6.56M |
|
417
Cheniere Energy
LNG
$52.9B
| $12.4M | 0.06% |
178,837
-366,725
| -67% | -$23.6M |
|
418
Vistra
VST
$47.4B
| $12.4M | 0.06% |
499,473
-786,172
| -61% | -$18.1M |
|
|
FFWM
419
DELISTED
First Foundation Inc
FFWM
| $12.4M | 0.06% |
+794,794
| New | +$13.4M |
|
|
LHO
420
DELISTED
LaSalle Hotel Properties
LHO
| $12.4M | 0.06% |
+358,860
| New | +$12.4M |
|
421
Waters Corp
WAT
$39.9B
| $12.4M | 0.06% |
63,708
-6,900
| -10% | -$1.34M |
|
422
Sally Beauty Holdings
SBH
$1.58B
| $12.4M | 0.06% |
+674,016
| New | +$10.8M |
|
423
Armstrong World Industries
AWI
$7.84B
| $12.4M | 0.06% |
177,514
-216,062
| -55% | -$14.9M |
|
|
SGEN
424
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.3M | 0.06% |
159,834
+63,214
| +65% | +$4.66M |
|
425
Regeneron Pharmaceuticals
REGN
$80.8B
| $12.2M | 0.06% |
30,274
+21,238
| +235% | +$8.08M |
|
Similar funds
CBU
BC
Balyasny Asset Management's Q3 2018 Portfolio in Review
As of Q3 2018, Balyasny Asset Management held 2,302 positions worth $22B, up 0% from $22B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Balyasny Asset Management withdrew a net $916M in Q3 2018, closing 688 positions and reducing 537 holdings. Its most notable exit was DuPont de Nemours, an estimated $144M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Balyasny Asset Management opened a new position in Equifax worth $132M.
- Balyasny Asset Management's largest Q3 2018 buy was Equifax: 1,013,016 shares worth $132M.
- Balyasny Asset Management added most to Walt Disney in Q3 2018, an estimated $168M increase.
- Balyasny Asset Management's biggest Q3 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $335M.
- Balyasny Asset Management fully exited DuPont de Nemours in Q3 2018, selling an estimated $144M.
- Balyasny Asset Management's ten largest holdings make up 11% of its $22B portfolio in Q3 2018.
- Balyasny Asset Management opened 567 new positions and closed 688 in Q3 2018.
- Balyasny Asset Management's portfolio value rose 0% quarter-over-quarter to $22B.
Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.